ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010

NCI Offers Bibliography On Risk Communication.

March 23, 2001

Clinical Research Program Announcement

February 13, 1981

NCI Advisory Group Meetings for September

August 29, 1975

DES Study Indicates Threat If Vaginal Cancer May Not Be Serious

November 15, 1974

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011